Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
Status:
Not yet recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of guselkumab treatment versus placebo
in skin of color participants with predominant moderate-to-severe body psoriasis or
predominant moderate-to-severe scalp psoriasis by assessing improvements in the signs and
symptoms of psoriasis.